XML 39 R30.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Earnings per share (Tables)
6 Months Ended
Jun. 30, 2024
Earnings Per Share [Abstract]  
Schedule of Earnings per Share

The following is a reconciliation of the numerator and denominator used to calculate basic earnings per share and diluted earnings per share for the three and six months ended June 30, 2024 and 2023:

 

 

Three Months Ended June 30,

 

 

For The Six Months Ended June 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

Calculation of basic and diluted loss per share
     attributable to the Company’s shareholders

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to the Company’s shareholders

 

$

(7,335,455

)

 

$

(6,880,886

)

 

$

(12,361,200

)

 

$

(14,234,706

)

Weighted-average common shares outstanding –
     basic and diluted

 

 

9,255,025

 

 

 

5,042,126

 

 

 

9,248,503

 

 

 

5,040,741

 

Net loss per share, basic and diluted

 

$

(0.79

)

 

$

(1.36

)

 

$

(1.34

)

 

$

(2.82

)

Summary of Anti-dilutive Shares Excluded from Calculation of Diluted Net Loss per Share The Company excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:

 

 

For The Six Months Ended June 30,

 

 

2024

 

 

2023

 

Stock options and awards

 

 

1,926,100

 

 

 

61,065

 

Convertible Debt

 

 

41,159

 

 

 

38,262

 

Common Stock Warrants (1)

 

 

2,233,407

 

 

 

1,383,289

 

Series A Preferred Stock (2)

 

 

6,704,122

 

 

 

 

Preferred Stock Warrants (3)

 

 

23,803,334

 

 

 

 

Contingently issuable Earnout Shares from unexercised Rollover
   Options

 

 

150,806

 

 

 

150,806

 

Total

 

 

34,858,928

 

 

 

1,633,422

 

(1)
Contained within common stock warrants are the 575,000 public warrants (the “Public Warrants”), 20,860 warrants held by assignees of Big Cypress Holdings, LLC (the “Private Placement Warrants”), 30,000 warrants held by Ladenburg
Thalmann & Co. Inc. (the “Ladenburg Warrants”), 736,337 warrants issued to the investors in the December 2022 Private Placement (the “PIPE Warrants”), 21,091 warrants issued to the placement agent in the December 2022 Private Placement (the “PIPE Placement Agent Warrants”), and 850,119 Preferred PIPE Placement Agent Warrants issued to the placement agent in the September 2023 Offering. See Note 12, Warrants for further details on the Company’s outstanding warrants.
(2)
Represents shares of common stock underlying 42,236 issued, outstanding, and convertible shares of Series A-2 Preferred Stock. See Note 10, Stockholders’ Equity for further details on the Company’s preferred stock.
(3)
Represents 6,800,953 and 17,002,381 common shares underlying 42,846 outstanding Tranche B Warrants and 107,115 outstanding Tranche C Warrants, respectively.